Please login to the form below
New Accounts: June - PR and medical education
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period March 2006 to May 2006 inclusive
The following tables list new pharmaceutical account wins notified to us by the winning
agencies for the period March 2006 to May 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
|
|
|
|
|
|
The Alliance for Better Bone (P&G; S-A) |
Actonel |
Osteoporosis |
Ketchum |
|
ABPI |
The Involved Patient Initiative |
N/A |
Shire Health London |
|
Altana Pharma |
Pantoprazole |
Gastrointestinal |
Shire Health London |
|
Apitope Technology |
Phase Ib/IIa therapeutic biological vaccine |
MS |
Healthcare Solutions |
|
AstraZeneca |
Crestor |
Cardiovascular |
Zaicom MMC |
|
GlaxoSmithKline |
HPV vaccine |
Gynaecology/oncology |
Succinct Communications |
|
GlaxoSmithKline |
Telzir |
HIV |
90TEN Healthcare |
|
GrÈnenthal International |
Transtec - publications planning |
Pain |
Zaicom MMC |
|
Kimberly-Clark |
InteguSeal |
Antimicrobial surgical skin preparation |
De Facto Medica |
|
Link Pharmaceuticals |
Gliadel implant |
Oncology |
Spink Consumer Relations |
|
Merck SantÈ |
Glucovance |
Type II diabetes |
De Facto Medica |
|
NICE |
At Ri-SK? awareness campaign |
Solar keratosis |
hsdcommunications |
|
NICE |
Quick Reference Guides |
N/A |
90TEN Healthcare |
|
Pfizer |
Oncology portfolio |
Managed entry |
Succinct Communications |
|
Plethora/Timm |
Osbon ErecAid |
Male sexual dysfunction |
De Facto Medica |
|
ProStrakan |
Rapinyl |
Breakthrough pain |
Litmus/CCA |
|
Recordati |
Zanidip |
Cardiology |
LeapFrog Medical Communications |
|
Roche Pharmaceuticals |
Fuzeon/Invirase |
HIV |
Aurora |
|
Schering-Plough |
Nasonex |
Respiratory disease |
LeapFrog Medical Communications |
|
Servier |
Various |
Cardiology |
Zaicom MMC |
|
Speedel |
SPP301 |
Hypertension |
De Facto Medica |
|
UCB |
Professional development programme |
ADHD |
Huntsworth Health Avenue |
|
Wyeth Consumer Health |
Anadin |
Analgesics |
Spink Consumer Relations |
Share
Related Hub content
Featured jobs
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Senior External Communications Lead
-
£Competitive Salary
-
Account Manager
-
£Competitive Salary
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account Director
-
£Competitive Salary
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Account Manager (PR)
-
Great Benefits
-
Experienced medical editor
-
Competitive salary and bonus scheme
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Publications director
-
Competitive salary and bonus scheme
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Account Director, Healthcare Communications
-
Salary TBC
-
Account director
-
Competitive salary and bonus scheme
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
Subscribe to our email news alerts
- US backs Sanofi’s ‘fast-track’ coronavirus vaccine
- Coronavirus outbreak escalation could impact drug supply chain
- FDA accepts review to broaden GSK’s Zejula label
- Roche’s Herceptin/Perjeta fixed-dose combo filed with FDA
- Celgene’s Revlimid scores NICE approval in follicular lymphoma
- Novo Nordisk awakens its ‘Sleeping Beauty’
- AVENIR GLOBAL appoints global healthcare lead
- Bedrock Group bolsters team with three key appointments
- AXON recognised for ‘excellence in wellbeing’ by Great Place to Work
- Celgene’s Revlimid scores NICE approval in follicular lymphoma
- Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC
- Menlo slumps as itching drug fails mid-stage trial
PMHub
infill healthcare communication
infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...
Latest intelligence
- The ALS patient journey
- Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
- Equipping your medical affairs teams with solutions to navigate the healthcare landscape
- Dr Tyler Ray, OPEN Health Medical Communications...
- Can protein degraders unlock ‘undruggable’ drug targets?
- Exploring a new and exciting area of small-molecule drug discovery...
Quick links
Infographics
